查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1594963

胚胎着床前基因检测的全球市场

Preimplantation Genetic Testing
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 89 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球胚胎着床前基因检测市场将达到 15 亿美元

2023 年全球胚胎着床前基因检测市场预计为 7.68 亿美元，预计到 2030 年将达到 15 亿美元，2023-2030 年分析期间复合年增长率为 9.9%。试剂和消耗品部分是本报告分析的细分市场之一，预计复合年增长率为 10.6%，在分析期末达到 7.941 亿美元。分析期间内，设备产业的复合年增长率预计为 8.9%。

美国市场预估为2.125亿美元，中国预期复合年增长率为9.3%

预计 2023 年美国胚胎着床前基因检测市场规模将达 2.125 亿美元。中国作为全球第二大经济体，预计到 2030 年市场规模将达到 2.269 亿美元，2023 年至 2030 年分析期间复合年增长率为 9.3%。其他值得注意的区域市场包括日本和加拿大，预计在分析期间复合年增长率分别为 9.3% 和 8.1%。在欧洲，德国的复合年增长率预计约为 8.1%。

全球胚胎着床前基因检测市场 - 主要趋势与驱动因素总结

对辅助生殖技术不断增长的需求如何塑造胚胎着床前基因检测市场？

胚胎着床前基因检测（PGT）市场正在经历显着成长，这主要是由于对体外受精（IVF）等辅助生殖技术（ART）的需求不断增加。随着全球不孕率的上升，越来越多的夫妇正在寻求先进的生殖选择来实现怀孕，导致 PGT 的利用率增加。该测试可以在胚胎着床前对胚胎进行某些遗传条件的筛检，从而增加成功怀孕的机会并降低遗传疾病的风险。将 PGT 纳入 IVF 程序已成为标准做法，并极大地影响了接受 ART 的夫妇的决策流程。随着基因检测技术的进步，PGT 已发展到可以为多种遗传疾病提供更准确、更全面的筛检，包括染色体异常、单基因疾病和非整倍体。

此外，一般人群对基因检测的认识和接受度不断提高，也促进了 PGT 市场的成长。有关基因检测益处的教育宣传活动和资讯的提供正在帮助准父母就其生殖健康做出明智的决定。这种趋势在年长的父母中尤其明显，由于母亲年龄较大，他们可能更关心孩子的遗传健康。越来越多的生育诊所提供此类服务也推动了对 PGT 的需求，这使得以前可能不知道我正在做的选择的夫妇更容易获得这种服务。随着消费者对基因检测信心的增强，胚胎着床前基因检测的市场也不断扩大。

技术进步将在胚胎着床前基因检测的发展中扮演什么角色？

技术进步透过实现更准确、更有效率的检测方法，在改变 PGT 格局方面发挥关键作用。次世代定序(NGS) 技术的引入彻底改变了基因检测，使得以更高的准确性和速度同时分析多个基因和染色体成为可能。 NGS有助于全面的胚胎着床前遗传学诊断（PGD）和胚胎着床前遗传学筛检（PGS），使临床医生能够更有效地识别胚胎中的遗传异常。该技术不仅提高了遗传异常的检出率，还减少了测试所需的时间，这对于 IVF 週期中胚胎选择的时间敏感至关重要。

此外，胚胎培养技术的进步和延时成像技术的发展改善了胚胎评估，使胚胎学家能够即时监测胚胎髮育。这些创新可以更好地选择可行的胚胎，从而优化成功植入和怀孕的机会。随着技术的不断发展，预计 PGT 将越来越多地与自动化系统集成，从而增强实验室工作流程并减少人为错误。这种整合将进一步简化基因检测流程，使其更有效率且可供患者使用。

消费者偏好的改变如何影响胚胎着床前基因检测市场？

消费者对个人化医疗保健偏好的变化正在对 PGT 服务的需求产生重大影响。随着遗传健康意识的增强，个人和夫妇越来越多地寻求符合其个人健康目标和生殖计划的选择。个人化医疗的趋势正在导致基因检测的接受度越来越高，消费者将 PGT 不仅视为遗传疾病的预防措施，而且视为调整生殖选择的一种手段。这种转变在千禧世代和 Z 世代消费者中尤其明显，他们优先考虑健康并积极控制自己的遗传健康。

此外，计划生育的愿望以及年轻一代延后生育的趋势也进一步推动了PGT的需求。当个人优先考虑自己的职业和个人成长时，他们经常寻求有助于降低与高龄产妇相关的风险（包括染色体异常）的生殖技术。由于这一趋势，基因检测逐渐被接受为不孕症治疗的常规部分，许多准父母认为 PGT 是 IVF 过程中的重要步骤。因此，生育诊所越来越多地提供 PGT 作为其服务的标准组成部分，以满足患者不断变化的期望。

推动胚胎着床前基因检测市场成长的因素有哪些？

胚胎着床前基因检测（PGT）市场的成长受到多种因素的推动，包括基因检测技术的进步、不孕率的上升以及消费者对基因健康意识的提高。次世代定序（NGS）和其他创新技术的进步极大地提高了PGT的准确性和效率，使其成为许多接受辅助生殖技术的准父母的首选。此外，随着越来越多的夫妻寻求增加成功怀孕的机会，不孕症的普遍存在和对 ART 解决方案不断增长的需求扩大了 PGT 的潜在市场。

此外，消费行为向个人化健康方向的改变也促进了 PGT 的日益普及。随着越来越多人意识到自己的遗传健康选择，对符合特定健康目标的客製化的生殖服务的期望也不断增加。提供这些服务的生育诊所的增加进一步促进了 PGT 与标准 IVF 的整合，使更多人更容易获得这些服务。对基因检测的监管支持和医疗保健政策的进步也在促进PGT的采用方面发挥着重要作用。这些因素结合起来，为胚胎着床前基因检测市场创造了强劲的成长环境，使其成为现代生殖保健的关键组成部分。

部分

组件（试剂和耗材、设备、软体和服务）、技术（次世代定序(NGS)、聚合酵素链锁反应(PCR)、萤光原位杂合技术(FISH)、其他技术）、最终用户（产科）中心和生育中心诊所、医院、诊断实验室和服务供应商、研究机构和学术机构）

受访企业范例（总合34 家知名企业）

  • Ariosa Diagnostics
  • Bioarray SL
  • California Pacific Medical Center（CPMC）
  • CombiMatrix
  • CooperSurgical, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Genea Limited
  • Genesis Genetics
  • Good Start Genetics, Inc.
  • IGENOMIX
  • Illumina, Inc.
  • Invitae Corporation
  • Laboratory Corporation of America Holdings
  • Natera, Inc.
  • Oxford Gene Technology
  • PerkinElmer Inc.
  • Quest Diagnostics Incorporated
  • Reproductive Genetic Innovations, LLC
  • Reprogenetics
  • RHS Ltd.
  • Sequenom
  • Thermo Fisher Scientific, Inc.

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他领域

第四章 比赛

简介目录
Product Code: MCP22620

Global Preimplantation Genetic Testing Market to Reach US$1.5 Billion by 2030

The global market for Preimplantation Genetic Testing estimated at US$768.0 Million in the year 2023, is expected to reach US$1.5 Billion by 2030, growing at a CAGR of 9.9% over the analysis period 2023-2030. Reagents & Consumables Component, one of the segments analyzed in the report, is expected to record a 10.6% CAGR and reach US$794.1 Million by the end of the analysis period. Growth in the Instruments Component segment is estimated at 8.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$212.5 Million While China is Forecast to Grow at 9.3% CAGR

The Preimplantation Genetic Testing market in the U.S. is estimated at US$212.5 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$226.9 Million by the year 2030 trailing a CAGR of 9.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.3% and 8.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.1% CAGR.

Global Preimplantation Genetic Testing Market – Key Trends & Drivers Summarized

How Is the Rising Demand for Assisted Reproductive Technologies Shaping the Preimplantation Genetic Testing Market?

The preimplantation genetic testing (PGT) market is undergoing significant growth, largely driven by the increasing demand for assisted reproductive technologies (ART) such as in vitro fertilization (IVF). As infertility rates rise globally, more couples are seeking advanced reproductive options to achieve pregnancy, leading to an uptick in the utilization of PGT. This testing allows for the screening of embryos for specific genetic conditions before implantation, thereby enhancing the chances of a successful pregnancy and reducing the risk of genetic disorders. The integration of PGT into IVF procedures has become a standard practice, significantly influencing the decision-making process for couples undergoing ART. With the advancements in genetic testing technologies, PGT has evolved to offer more accurate and comprehensive screening for a wide range of genetic disorders, including chromosomal abnormalities, single-gene disorders, and aneuploidies.

Moreover, the increasing awareness and acceptance of genetic testing in the general population are contributing to the growth of the PGT market. Educational campaigns and the availability of information regarding the benefits of genetic testing have empowered prospective parents to make informed decisions about their reproductive health. This trend is particularly pronounced among older parents who may be more concerned about the genetic health of their children due to advanced maternal age. The demand for PGT is also fueled by the increasing number of fertility clinics offering these services, making PGT more accessible to couples who may have previously been unaware of their options. As consumer confidence in genetic testing grows, so does the market for preimplantation genetic testing.

What Role Do Technological Advancements Play in the Evolution of Preimplantation Genetic Testing?

Technological advancements are playing a crucial role in transforming the PGT landscape, enabling more precise and efficient testing methods. The introduction of next-generation sequencing (NGS) technologies has revolutionized genetic testing, allowing for the simultaneous analysis of multiple genes and chromosomes with greater accuracy and speed. NGS facilitates comprehensive preimplantation genetic diagnosis (PGD) and preimplantation genetic screening (PGS), enabling clinicians to identify genetic abnormalities in embryos more effectively. This technology not only enhances the detection rates of genetic disorders but also reduces the time required for testing, which is critical in the time-sensitive context of embryo selection during IVF cycles.

Furthermore, advancements in embryo culture techniques and the development of time-lapse imaging technologies have improved embryo assessment, enabling embryologists to monitor embryo development in real time. These innovations allow for better selection of viable embryos, thus optimizing the chances of successful implantation and pregnancy. As the technology continues to evolve, it is anticipated that PGT will become increasingly integrated with automated systems that enhance laboratory workflows and reduce human error. This integration will further streamline the process of genetic testing, making it more efficient and accessible for patients.

How Are Changing Consumer Preferences Influencing the Preimplantation Genetic Testing Market?

Changing consumer preferences towards personalized healthcare are significantly influencing the demand for PGT services. As awareness about genetic health increases, individuals and couples are more inclined to seek options that align with their personal health goals and reproductive plans. The trend towards personalized medicine has led to a greater acceptance of genetic testing, as consumers view PGT not only as a preventive measure against hereditary diseases but also as a means to tailor their reproductive choices. This shift is particularly evident among millennials and Gen Z consumers, who prioritize health and wellness and are proactive about managing their genetic health.

Additionally, the desire for family planning and the growing trend of delayed parenthood among younger generations further drive the demand for PGT. As individuals prioritize career and personal development, they often seek reproductive technologies that can help mitigate the risks associated with advanced maternal age, including chromosomal abnormalities. This trend has led to a growing acceptance of genetic testing as a routine part of the fertility journey, with many prospective parents considering PGT an essential step in the IVF process. As a result, fertility clinics are increasingly offering PGT as a standard component of their services to meet the evolving expectations of their patients.

What Factors Are Driving Growth in the Preimplantation Genetic Testing Market?

The growth in the preimplantation genetic testing (PGT) market is driven by several factors, including advancements in genetic testing technologies, increasing infertility rates, and rising consumer awareness of genetic health. The evolution of next-generation sequencing (NGS) and other innovative technologies has significantly improved the accuracy and efficiency of PGT, making it a preferred choice for many prospective parents undergoing assisted reproductive technologies. Additionally, the growing prevalence of infertility and the demand for ART solutions have expanded the addressable market for PGT, as couples seek to enhance their chances of a successful pregnancy.

Moreover, changing consumer behaviors towards personalized health and wellness are contributing to the increased adoption of PGT. As more individuals become informed about their genetic health options, there is a rising expectation for tailored reproductive services that align with their specific health goals. The integration of PGT into standard IVF practices is further fueled by the increasing number of fertility clinics offering these services, making them more accessible to a broader population. Regulatory support for genetic testing and advancements in healthcare policies also play a significant role in promoting the adoption of PGT. Together, these factors create a robust growth environment for the preimplantation genetic testing market, positioning it as a critical component of modern reproductive health care.

SCOPE OF STUDY:

The report analyzes the Preimplantation Genetic Testing market in terms of US$ Thousand by the following Component; End-Use; Technology, and Geographic Regions/Countries:

Segments:

Component (Reagents & Consumables, Instruments, Software & Services); Technology (Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH), Other Technologies); End-Use (Maternity Centers & Fertility Clinics, Hospitals, Diagnostic Labs & Service Providers, Research Laboratories & Academic Institutes)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 34 Featured) -

  • Ariosa Diagnostics
  • Bioarray S.L.
  • California Pacific Medical Center (CPMC)
  • CombiMatrix
  • CooperSurgical, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Genea Limited
  • Genesis Genetics
  • Good Start Genetics, Inc.
  • IGENOMIX
  • Illumina, Inc.
  • Invitae Corporation
  • Laboratory Corporation of America Holdings
  • Natera, Inc.
  • Oxford Gene Technology
  • PerkinElmer Inc.
  • Quest Diagnostics Incorporated
  • Reproductive Genetic Innovations, LLC
  • Reprogenetics
  • RHS Ltd.
  • Sequenom
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Preimplantation Genetic Testing - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Assisted Reproductive Technologies (ART) Drives Adoption of Preimplantation Genetic Testing (PGT)
    • Increasing Awareness of Genetic Disorders Expands the Addressable Market for Preimplantation Genetic Testing
    • Advancements in Next-Generation Sequencing (NGS) Propel Growth in Preimplantation Genetic Testing for Enhanced Accuracy
    • Growing Focus on Improving In Vitro Fertilization (IVF) Success Rates Strengthens the Business Case for Preimplantation Genetic Testing
    • Increasing Incidence of Genetic Disorders and Chromosomal Abnormalities Spurs Demand for PGT in Fertility Treatments
    • Technological Advancements in Embryo Biopsy Techniques Expand Opportunities for Preimplantation Genetic Testing
    • Rising Adoption of Non-Invasive Genetic Testing Methods Drives Innovation in Preimplantation Genetic Testing
    • Growing Trend Toward Delayed Parenthood Expands Demand for Preimplantation Genetic Testing in Older Patients
    • Increasing Focus on Personalized Medicine in Reproductive Health Expands the Use of Preimplantation Genetic Testing
    • Rising Consumer Demand for Family Planning Solutions Propels Growth in Preimplantation Genetic Testing Market
    • Growing Use of Preimplantation Genetic Testing for Gender Selection Creates New Market Opportunities
    • Expanding Use of Preimplantation Genetic Testing in Detecting Single-Gene Disorders Strengthens Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Preimplantation Genetic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Preimplantation Genetic Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Reagents & Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Software & Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Research Laboratories & Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Research Laboratories & Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Research Laboratories & Academic Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Maternity Centers & Fertility Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Maternity Centers & Fertility Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Maternity Centers & Fertility Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Hospitals, Diagnostic Labs & Service Providers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Hospitals, Diagnostic Labs & Service Providers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Hospitals, Diagnostic Labs & Service Providers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Next Generation Sequencing (NGS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Next Generation Sequencing (NGS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Polymerase Chain Reaction (PCR) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Polymerase Chain Reaction (PCR) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 27: World 16-Year Perspective for Polymerase Chain Reaction (PCR) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Fluorescent In-Situ Hybridization (FISH) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Fluorescent In-Situ Hybridization (FISH) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 30: World 16-Year Perspective for Fluorescent In-Situ Hybridization (FISH) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 33: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 34: World Preimplantation Genetic Testing Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Preimplantation Genetic Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Preimplantation Genetic Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Preimplantation Genetic Testing by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers for the Years 2014, 2024 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Preimplantation Genetic Testing by Technology - Percentage Breakdown of Value Sales for Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Preimplantation Genetic Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Preimplantation Genetic Testing by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers for the Years 2014, 2024 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Preimplantation Genetic Testing by Technology - Percentage Breakdown of Value Sales for Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies for the Years 2014, 2024 & 2030
  • JAPAN
    • Preimplantation Genetic Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Preimplantation Genetic Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Preimplantation Genetic Testing by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers for the Years 2014, 2024 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Preimplantation Genetic Testing by Technology - Percentage Breakdown of Value Sales for Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies for the Years 2014, 2024 & 2030
  • CHINA
    • Preimplantation Genetic Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Preimplantation Genetic Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: China 16-Year Perspective for Preimplantation Genetic Testing by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers for the Years 2014, 2024 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: China 16-Year Perspective for Preimplantation Genetic Testing by Technology - Percentage Breakdown of Value Sales for Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies for the Years 2014, 2024 & 2030
  • EUROPE
    • Preimplantation Genetic Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Preimplantation Genetic Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Preimplantation Genetic Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Preimplantation Genetic Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Preimplantation Genetic Testing by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers for the Years 2014, 2024 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Preimplantation Genetic Testing by Technology - Percentage Breakdown of Value Sales for Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies for the Years 2014, 2024 & 2030
  • FRANCE
    • Preimplantation Genetic Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 83: France Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: France 16-Year Perspective for Preimplantation Genetic Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: France 16-Year Perspective for Preimplantation Genetic Testing by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers for the Years 2014, 2024 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: France 16-Year Perspective for Preimplantation Genetic Testing by Technology - Percentage Breakdown of Value Sales for Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies for the Years 2014, 2024 & 2030
  • GERMANY
    • Preimplantation Genetic Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Preimplantation Genetic Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for Preimplantation Genetic Testing by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers for the Years 2014, 2024 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for Preimplantation Genetic Testing by Technology - Percentage Breakdown of Value Sales for Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Preimplantation Genetic Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for Preimplantation Genetic Testing by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers for the Years 2014, 2024 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for Preimplantation Genetic Testing by Technology - Percentage Breakdown of Value Sales for Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Preimplantation Genetic Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 110: UK Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Preimplantation Genetic Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: UK 16-Year Perspective for Preimplantation Genetic Testing by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers for the Years 2014, 2024 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: UK 16-Year Perspective for Preimplantation Genetic Testing by Technology - Percentage Breakdown of Value Sales for Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: Rest of Europe 16-Year Perspective for Preimplantation Genetic Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Europe 16-Year Perspective for Preimplantation Genetic Testing by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers for the Years 2014, 2024 & 2030
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Europe 16-Year Perspective for Preimplantation Genetic Testing by Technology - Percentage Breakdown of Value Sales for Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Preimplantation Genetic Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Asia-Pacific 16-Year Perspective for Preimplantation Genetic Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Asia-Pacific 16-Year Perspective for Preimplantation Genetic Testing by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers for the Years 2014, 2024 & 2030
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Asia-Pacific 16-Year Perspective for Preimplantation Genetic Testing by Technology - Percentage Breakdown of Value Sales for Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 137: Rest of World Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of World Historic Review for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of World 16-Year Perspective for Preimplantation Genetic Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Rest of World 16-Year Perspective for Preimplantation Genetic Testing by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers for the Years 2014, 2024 & 2030
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Rest of World 16-Year Perspective for Preimplantation Genetic Testing by Technology - Percentage Breakdown of Value Sales for Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies for the Years 2014, 2024 & 2030

IV. COMPETITION